Confocal infrared RM imaging of macular diseases

Article

Ability to observe details of deep retinal structures noninvasively and clearly

The RM imaging enables investigators to observe the details of deep retinal structures, noninvasively and clearly, by illuminating the fundus with an infrared laser and collecting the scattered light reflected from the retina and choroid through a semicircular and pericentral aperture by a new confocal technique. This allows for a clearer pseudo three-dimensional image, which is a new method of detecting abnormalities in the macula.1

Some advantages of using the F10 SLO to examine the macula are: non-invasive procedure, short testing time and the entire extent of the macula can be obtained in one image under non-mydriatic conditions.

This report aims to show some macular diseases features in which this imaging method could be helpful.

Drusen

RM imaging has been reported to detect more drusen then conventional color fundus photography.2 The drusen borders, by this imaging method are well highlighted, making them easier to manually segment and grade.

The measurements of drusen number and area obtained by RM were compared with those obtained using standard colour fundus photography. Drusen number grades were found to be significantly higher using the right (AR) and left (AL) lateral apertures in which the laterally scattered light is captured.

The mean drusen number detection with the AR retromode was almost two times greater than for the colour photographs. Small drusen, as well as drusen more distant from the fovea, were more easily visualized with the AR and AL retromodes. The AR retromode would probably be preferred and recommended in further comparative studies; while drusen appear in an elevated convex shape in the AR, in the AL the conformation seems to be inverted.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
Related Content
© 2025 MJH Life Sciences

All rights reserved.